Erik Klok, MD, PhD, FESC

Leiden University Medical Center

Prof. F.A. (Erik) Klok is a board-certified specialist in Internal Medicine, with a specialty in vascular medicine in the Leiden University Medical Center (Leiden, the Netherlands) and holds a position as visiting professor at the Center for thrombosis and Hemostasis in Mainz (Germany). This allows him to combine clinical work with scientific activities. His research interests include the diagnosis, treatment and long-term complications of venous thromboembolism.

Presentation(s):

• OC 01.4 - Prevalence of chronic thromboembolic pulmonary hypertension and evaluation of thrombus resolution in COVID-19-associated pulmonary embolism survivors

  Saturday, June 24, 2023
  13:45 – 14:00 ET

• OC 11.1 - Development and validation of a clinical prediction model for the diagnostic management of acute pulmonary embolism: an individual participant data meta-analysis

  Sunday, June 25, 2023
  10:45 – 11:00 ET

• OC 11.5 - Diagnostic strategies in patients on anticoagulation presenting with a suspicion of recurrent venous thromboembolism

  Sunday, June 25, 2023
  11:45 – 12:00 ET

• OC 29.2 - The impact of pulmonary embolism on the long-term health outcomes of COVID-19

  Sunday, June 25, 2023
  15:00 – 15:15 ET

• PB0447 - Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: an update of the literature

  Sunday, June 25, 2023
  18:30 – 19:30 ET

• PB0479 - The ABC-bleeding score for prediction of on-treatment clinically relevant bleeding in patients with unprovoked venous thromboembolism: results from the prospective PLATO-VTE study

  Sunday, June 25, 2023
  18:30 – 19:30 ET

• PB0481 - A randomized controlled trial to evaluate the efficacy of an 8-week standardized exercise training program for preventing post-pulmonary embolism syndrome: rationale & design of the PE@HOME study

  Sunday, June 25, 2023
  18:30 – 19:30 ET

• OC 40.6 - Management of Venous Thromboembolism II

  Monday, June 26, 2023
  14:45 – 16:00 ET

• OC 40.2 - Outcomes of home treatment of acute pulmonary embolism in clinically relevant patient subgroups: A systematic review and individual-patient data meta-analysis

  Monday, June 26, 2023
  15:00 – 15:15 ET

• OC 46.1 - Absolute quantitative proteomics for occult cancer screening in patient with unprovoked venous thromboembolism: results from the prospective PLATO-VTE study

  Monday, June 26, 2023
  14:45 – 15:00 ET

• PB0699 - Idarucizumab for Dabigatran Reversal: a Systematic Review and Meta-analysis of Indications and Outcomes

  Monday, June 26, 2023
  18:30 – 19:30 ET

• PB0961 - Towards cancer patient empowerment for optimal use of antithrombotic therapy at the end of life: a research protocol for the development and implementation of the SERENITY shared-decision support tool

  Monday, June 26, 2023
  18:30 – 19:30 ET

• PB1008 - The diagnostic performance of the YEARS and PEGeD algorithm in patients with prior venous thrombosis suspected of pulmonary embolism

  Monday, June 26, 2023
  18:30 – 19:30 ET

• SSC 20.10 - Risk assessment in acute pulmonary embolism

  Tuesday, June 27, 2023
  18:04 – 18:14 ET

• OC 71.2 - Discharging cancer patients with acute pulmonary embolism from the emergency department: a multicenter cohort study

  Wednesday, June 28, 2023
  10:30 – 10:45 ET

• OC 74.3 - Anticoagulant use and prognosis in patients with atrial fibrillation and cancer: a nationwide population-based study

  Wednesday, June 28, 2023
  10:45 – 11:00 ET

• OC 74.4 - Prevalence and Predictors of Non-Adherence to Direct Oral Anticoagulant Treatment in Patients with Atrial Fibrillation, a Historical Cohort Study

  Wednesday, June 28, 2023
  11:00 – 11:15 ET